Women in IP Speaker Series: Implications for the Life Sciences Industry of President Biden's Executive Order on Promoting Competition and the Inflation Reduction Act

President Biden's Executive Order on Promoting Competition in the American Economy tasks federal agencies with setting policies "[t]o avoid the potential for anticompetitive extension of market power beyond the scope of granted patents" and to ensure that the patent system does not "unjustifiably delay generic drug and biosimilar competition."

Responses from the agencies have included the following: 

• A policy statement from the Federal Trade Commission regarding Orange Book listings; and
• A collaboration initiative between the U.S. Food and Drug Administration and the U.S. Patent and Trademark Office. 

In addition, the Inflation Reduction Act (IRA) seeks to lower prescription drug costs for Medicare patients through, e.g., biosimilar and generic competition or reduced prices for drugs without such competition. 

Please join us for the latest program in our Women in IP Speaker Series, which will discuss these agency policies and initiatives and the IRA, as well as their possible implications for the biotech/pharma industry and investors.

REGISTER NOW

SPEAKERS

• Gloria Fuentes, Vice President & Assistant General Counsel, Bristol-Myers Squibb
• Jennifer J. Chheda, Ph.D., Partner, Jones Day, New York
• Sarah A. Geers, Partner, Jones Day, New York
• Randi Lesnick, Partner, Jones Day, New York
• Lisamarie LoGiudice, Ph.D., Of Counsel, Jones Day, New York

CONTACT

For more information, please contact womeninip@jonesday.com.

CLE INFORMATION

This program has been approved for 1.00 hour of general credit by the State Bar of California and 1.00 hour of areas of professional practice credit (including transitional credit) by the New York State CLE Board. Jones Day is a State Bar of California MCLE approved provider, as well as an accredited provider in New York. New Jersey attorneys who take courses approved in another mandatory CLE state will receive 1:1 credit for courses approved in that jurisdiction through reciprocity. No credit will be issued for Minnesota in accordance with Minnesota CLE Board Rule 5.B. Pennsylvania credit is not available for this program. Application for CLE credit in other states will be made as needed, subject to state CLE regulations.